scholarly journals Design, synthesis, and anti-HIV-1 activity of 1-substituted 3-(3,5-dimethylbenzyl)triazine derivatives

2015 ◽  
Vol 24 (2) ◽  
pp. 62-71 ◽  
Author(s):  
Norikazu Sakakibara ◽  
Gianfranco Balboni ◽  
Cenzo Congiu ◽  
Valentina Onnis ◽  
Yosuke Demizu ◽  
...  
2016 ◽  
Vol 24 (9) ◽  
pp. 2125-2136 ◽  
Author(s):  
Liang Yang ◽  
Ping Wang ◽  
Ji-Feng Wu ◽  
Liu-Meng Yang ◽  
Rui-Rui Wang ◽  
...  
Keyword(s):  
Anti Hiv ◽  

2017 ◽  
Vol 7 (10) ◽  
Author(s):  
Suresh C Jadhavar ◽  
Sujit G Bhansali ◽  
Shivaji B Patwari ◽  
Sudhakar R Bhusare ◽  
Hanmant M Kasralikar

2021 ◽  
Vol 17 ◽  
Author(s):  
Nafiseh Karimi ◽  
Rouhollah Vahabpour Roudsari ◽  
Zahra Hajimahdi ◽  
Afshin Zarghi

Background: Integrase enzyme is a validated drug target to discover novel structures as anti-HIV-1 agents. Objective: Novel series of thioimidazolyl diketo acid derivatives characterizing various substituents at N-1 and 2-thio positions of central ring were developed as HIV-1 integrase inhibitors. Results: The obtained molecules were evaluated in the enzyme assay, displaying promising integrase inhibitory activity with IC50 values ranging from 0.9 to 7.7 M. The synthesized compounds were also tested for antiviral activity and cytotoxicity using HeLa cells infected by the single-cycle replicable HIV-1 NL4-3. Conclusion: The most potent compound was 18i with EC50=19 µM, IC50 0.9 µM and SI= 10.5. Docking studies indicated that the binding mode of the active molecule is well aligned with the known HIV-1 integrase inhibitors.


Drug Research ◽  
2013 ◽  
Vol 63 (04) ◽  
pp. 192-197 ◽  
Author(s):  
Z. Hajimahdi ◽  
R. Zabihollahi ◽  
M. Aghasadeghi ◽  
A. Zarghi

2015 ◽  
Vol 24 (1) ◽  
pp. 3-18 ◽  
Author(s):  
Norikazu Sakakibara ◽  
Masanori Baba ◽  
Mika Okamoto ◽  
Masaaki Toyama ◽  
Yosuke Demizu ◽  
...  

2017 ◽  
Vol 140 ◽  
pp. 383-391 ◽  
Author(s):  
Zhaoqiang Liu ◽  
Ye Tian ◽  
Jinghan Liu ◽  
Boshi Huang ◽  
Dongwei Kang ◽  
...  
Keyword(s):  
Anti Hiv ◽  

2016 ◽  
Vol 67 ◽  
pp. 75-83 ◽  
Author(s):  
Subhash Chander ◽  
Ping Wang ◽  
Penta Ashok ◽  
Liu-Meng Yang ◽  
Yong-Tang Zheng ◽  
...  

2020 ◽  
Vol 16 (7) ◽  
pp. 938-946 ◽  
Author(s):  
Mahdieh Safakish ◽  
Zahra Hajimahdi ◽  
Rouhollah Vahabpour ◽  
Rezvan Zabihollahi ◽  
Afshin Zarghi

Introduction: Integrase is a validated drug target for anti-HIV-1 therapy. The second generation integrase inhibitors display π-stacking interaction ability with 3’-end nucleotide as a streamlined metal chelating pharmacophore. Method: In this study, we introduced benzoxazin-3-one scaffold for integrase inhibitory potential as bioisostere replacement strategy of 2-benzoxazolinone. Results: Molecular modeling studies revealed that amide functionality alongside oxadiazole heteroatoms and sulfur in the second position of oxadiazole ring could mimic the metal chelating pharmacophore. The halobenzyl ring occupies hydrophobic site created by the cytidylate nucleotide (DC-16). Conclusion: The most potent and selective compound displayed 110 μM IC50 with a selectivity index of more than 2.


2017 ◽  
Vol 27 (1) ◽  
pp. 61-65 ◽  
Author(s):  
Subhash Chander ◽  
Ping Wang ◽  
Penta Ashok ◽  
Liu-Meng Yang ◽  
Yong-Tang Zheng ◽  
...  
Keyword(s):  
Anti Hiv ◽  

2014 ◽  
Vol 12 (21) ◽  
pp. 3446-3458 ◽  
Author(s):  
Hai-Xia Jiang ◽  
Dao-Min Zhuang ◽  
Ying Huang ◽  
Xing-Xin Cao ◽  
Jian-Hua Yao ◽  
...  

A novel series of trifluoromethyl indoles have been designed, synthesized and evaluated for anti-HIV-1 activities.


Sign in / Sign up

Export Citation Format

Share Document